Last reviewed · How we verify
Venetoclax MTD with Dexamethasone
Venetoclax MTD with Dexamethasone is a Small molecule drug developed by Rajshekhar Chakraborty, MD. It is currently in Phase 1 development.
At a glance
| Generic name | Venetoclax MTD with Dexamethasone |
|---|---|
| Sponsor | Rajshekhar Chakraborty, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis (PHASE1, PHASE2)
- Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (PHASE1, PHASE2)
- A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma (PHASE1)
- A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Venetoclax MTD with Dexamethasone CI brief — competitive landscape report
- Venetoclax MTD with Dexamethasone updates RSS · CI watch RSS
- Rajshekhar Chakraborty, MD portfolio CI
Frequently asked questions about Venetoclax MTD with Dexamethasone
What is Venetoclax MTD with Dexamethasone?
Venetoclax MTD with Dexamethasone is a Small molecule drug developed by Rajshekhar Chakraborty, MD.
Who makes Venetoclax MTD with Dexamethasone?
Venetoclax MTD with Dexamethasone is developed by Rajshekhar Chakraborty, MD (see full Rajshekhar Chakraborty, MD pipeline at /company/rajshekhar-chakraborty-md).
What development phase is Venetoclax MTD with Dexamethasone in?
Venetoclax MTD with Dexamethasone is in Phase 1.